Manning & Napier Advisors’s Guardant Health GH Stock Holding History

Manning & Napier Advisors’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.46K	Buy	+16	New	+$1.74K	﹤0.01%	708

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Manning & Napier Advisors's GH Position: Q2 2026 in Review

Manning & Napier Advisors opened a new position in Guardant Health (GH) in Q2 2026: 16 shares worth $2.46K. The stake represents ﹤0.01% of the portfolio and ranks #708 among its holdings.

597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Manning & Napier Advisors held 16 shares of Guardant Health worth $2.46K as of Q2 2026.
Guardant Health was a new Manning & Napier Advisors position in Q2 2026.
Guardant Health made up ﹤0.01% of Manning & Napier Advisors's portfolio in Q2 2026, its #708 holding.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Manning & Napier Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.